Semler Scientific Reports Q3 2025 Revenue of $6.9–$7.5 Million, Expects Significant Q4 Decline

Reuters

10/04

<a href="https://laohu8.com/S/SMLR">Semler Scientific</a> Reports Q3 2025 Revenue of $6.9-$7.5 Million, Expects Significant Q4 Decline

Semler Scientific reported preliminary unaudited financial results for the third quarter ended September 30, 2025. Revenues for the period are expected to be between $6.9 million and $7.5 million. Operating expenses are anticipated to range from $12.8 million to $13.4 million, including approximately $2.1 million of non-cash stock compensation and depreciation, and $2.1 million of non-recurring merger-related consulting and professional fees. The company reported an unrealized gain from the change in fair value of Bitcoin holdings since June 30, 2025, of approximately $30.0 million. A customer accounting for more than 10% of revenue in each of the second and third quarters of 2025 has ceased use of QuantaFlo devices. The company expects fourth quarter 2025 revenues to be at least 60% lower compared to third quarter 2025 expected revenue, with further declines anticipated as other customers discontinue use of QuantaFlo devices.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Semler Scientific Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001554859-25-000053), on October 03, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2572633919"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2572633919\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2572633919?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-04 04:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2572633919","market":"nz","top_or_hot":-1,"title":"Semler Scientific Reports Q3 2025 Revenue of $6.9–$7.5 Million, Expects Significant Q4 Decline","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/SMLR\">Semler Scientific</a> Reports Q3 2025 Revenue of $6.9-$7.5 Million, Expects Significant Q4 Decline\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Semler Scientific reported preliminary unaudited financial results for the third quarter ended September 30, 2025. Revenues for the period are expected to be between $6.9 million and $7.5 million. Operating expenses are anticipated to range from $12.8 million to $13.4 million, including approximately $2.1 million of non-cash stock compensation and depreciation, and $2.1 million of non-recurring merger-related consulting and professional fees. The company reported an unrealized gain from the change in fair value of Bitcoin holdings since June 30, 2025, of approximately $30.0 million. A customer accounting for more than 10% of revenue in each of the second and third quarters of 2025 has ceased use of QuantaFlo devices. The company expects fourth quarter 2025 revenues to be at least 60% lower compared to third quarter 2025 expected revenue, with further declines anticipated as other customers discontinue use of QuantaFlo devices.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Semler Scientific Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001554859-25-000053), on October 03, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Semler Scientific Reports Q3 2025 Revenue of $6.9–$7.5 Million, Expects Significant Q4 Decline</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSemler Scientific Reports Q3 2025 Revenue of $6.9–$7.5 Million, Expects Significant Q4 Decline\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-04 04:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/SMLR\">Semler Scientific</a> Reports Q3 2025 Revenue of $6.9-$7.5 Million, Expects Significant Q4 Decline\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Semler Scientific reported preliminary unaudited financial results for the third quarter ended September 30, 2025. Revenues for the period are expected to be between $6.9 million and $7.5 million. Operating expenses are anticipated to range from $12.8 million to $13.4 million, including approximately $2.1 million of non-cash stock compensation and depreciation, and $2.1 million of non-recurring merger-related consulting and professional fees. The company reported an unrealized gain from the change in fair value of Bitcoin holdings since June 30, 2025, of approximately $30.0 million. A customer accounting for more than 10% of revenue in each of the second and third quarters of 2025 has ceased use of QuantaFlo devices. The company expects fourth quarter 2025 revenues to be at least 60% lower compared to third quarter 2025 expected revenue, with further declines anticipated as other customers discontinue use of QuantaFlo devices.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Semler Scientific Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001554859-25-000053), on October 03, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SMLR","symbol_name":"Semler Scientific, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nNDL27mthw:1","article_id":"2572633919","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2572633919","pubTimestamp":1759522758,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Semler Scientific reported preliminary unaudited financial results for the third quarter ended September 30, 2025. Revenues for the period are expected to be between $6.9 million and $7.5 million. Operating expenses are anticipated to range from $12.8 million to $13.4 million, including approximately $2.1 million of non-cash stock compensation and depreciation, and $2.1 million of non-recurring merger-related consulting and professional fees. The company reported an unrealized gain from the change in fair value of Bitcoin holdings since June 30, 2025, of approximately $30.0 million. A customer accounting for more than 10% of revenue in each of the second and third quarters of 2025 has ceased use of QuantaFlo devices. The company expects fourth quarter 2025 revenues to be at least 60% lower compared to third quarter 2025 expected revenue, with further declines anticipated as other customers discontinue use of QuantaFlo devices.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SMLR":"Semler Scientific, Inc.","BK4082":"医疗保健设备"},"translate_title":"Semler Scientific报告2025年第三季度收入为6.9-750万美元，预计第四季度将大幅下降","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SMLR":0.9},"content_text":"Semler Scientific Reports Q3 2025 Revenue of $6.9-$7.5 Million, Expects Significant Q4 Decline\n    \n\n        Semler Scientific reported preliminary unaudited financial results for the third quarter ended September 30, 2025. Revenues for the period are expected to be between $6.9 million and $7.5 million. Operating expenses are anticipated to range from $12.8 million to $13.4 million, including approximately $2.1 million of non-cash stock compensation and depreciation, and $2.1 million of non-recurring merger-related consulting and professional fees. The company reported an unrealized gain from the change in fair value of Bitcoin holdings since June 30, 2025, of approximately $30.0 million. A customer accounting for more than 10% of revenue in each of the second and third quarters of 2025 has ceased use of QuantaFlo devices. The company expects fourth quarter 2025 revenues to be at least 60% lower compared to third quarter 2025 expected revenue, with further declines anticipated as other customers discontinue use of QuantaFlo devices.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Semler Scientific Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001554859-25-000053), on October 03, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}